Abstract

The world is fighting an unexpected event of a pandemic. All over the world, people are living in fear of health of their own or family or the society World Health Origination says vaccination is the only solution to get rid of this COVID-19 pandemic. Vaccination needs effective and efficient management. Bangladesh, a developing South Asia with around 170 million population, is at high risk. On 8 March 2020, the first case of COVID-19 officially declared 1,580,559 confirmed cases and 28,041 deaths till now. This study aims to investigate and review the management and associated challenges of COVID19 vaccination in Bangladesh. The study will review various existing literature including research articles, newspapers, government statements. The article will criticize the management efforts in different stages of the process. The scientific papers and renowned national and international newspaper articles are considered for examining the literature. The scope of the research kept limited to the extent management and challenges of COVID-19 vaccination of Bangladesh are relevant. This will be a basis to conduct further researches to know in-depth. This study also criticizes the fact that the government was not much in favor of taking suggestions from external bodies like UK Research and Innovation (UKRI) and the Centre for Disease Control and Prevention (CDC), which could improve and handle the situation in a much efficient way. The study dissects the whole COVID-19 vaccination of Bangladesh into significant e segments. It tries to appreciate the good initiatives while denouncing the poor actions. It contributes by anatomizing, cherishing, and criticizing the management actions to bring attention to these points and develop the vaccine management process. It will help identify the flaws in the strategic implication of procuring the vaccine, which will further hint for the authority to consider arranging such initiatives. It will portray the lack of organizing and control, which is creating a chaotic situation in the vaccination campaign. Relevant authorities can consider the study to do further research to smooth the management process. As a result, the resources will the effectively used and efficiency will be ensured as the process will speed up.

Highlights

  • IntroductionPeople are living in fear of health of their own or family or the society (Scott, 2020)

  • The world is fighting an unexpected event of a pandemic

  • Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the pathogen which causes COVID-19 is a form of beta coronavirus which is genetically homologous to the SARS coronavirus of the year 2003 epidemic (SARS-CoV) (Wu et al, 2020)

Read more

Summary

Introduction

People are living in fear of health of their own or family or the society (Scott, 2020). Recent researches show that 'Remdesivir' developed by Gilead, is the most advanced type of antiviral drug has shortened the patient's recovery time by 4 days from 11 to 15 days, and it reduces the mortality by 14 days from 11.9 to 7.1%. (Wang Y, et al 2020b) many antiviral drugs are being in use, there is barely anyone found to be totally effective for all patients. This is why it is absolutely important to vaccinate the entire population as fast as possible as vaccination still is the most effective option available. It's a hard task to develop a vaccine but it is even harder to distribute and administer it effectively and efficiently, especially to the developing and underdeveloped countries which have a lack of proper distribution and administering logistics and expertise (Wang et al, 2020a)

Objectives
Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call